Boston Scientific is the latest cardiovascular company to pair up with healthcare providers and software makers to extend its reach.

Marie Thibault

Like its competitor, Medtronic, Boston Scientific has found itself working more closely with hospitals to help centers increase efficiency and save money. Unlike Medtronic, however, the Marlborough, MA-based company will not directly manage hospital catheterization (cath) labs to do this.

On April 30, Boston Scientific announced two new partnerships outside of its usual device relationships. Under an agreement with MedAxiom, which is a cardiovascular consulting company and network for healthcare providers, Boston Scientific will design and offer programs to improve cardiovascular care and to help centers put in place methods of becoming more...

May 4th, 2015
0

For technology to have big impact on healthcare, care programs need to be reinvented as technology alone cannot improve outcomes and reduce costs.

Arundhati Parmar

It's an exciting time in healthcare, believes Sean Hughes, vice president at Philips design who leads the firm's its strategic design consulting effort.

Data and connected devices are helping to move healthcare beyond the walls of the hospital into other care settings including the home. But while technology can enable the transition, ultimately success will be tied to how processes, design and care delivery programs evolve to meet the new demands caring for patients at home. Moving care of patients to their homes and monitoring them remotely leveraging technology is a...

May 1st, 2015
0

What are the best uses for 3-D printing in medical devices today?

Andy Pfahnl, ScD

The medical device industry is embracing 3-D printing for a range of applications that include true medical devices and clinical use, and not just for medical or health-related products. We look at the three top reasons to consider 3D printing for medical devices by examining specific applications best suited for the state of the additive manufacturing technology.

Background

Medical devices are regulated and categorized according to risk level, which in general reflects the rigor required in their development. The adoption of 3-D printing for medical devices is in part gated by the rigor in verification and validation of designs and processes that are required with particular consideration of mechanical and thermal properties, and biocompatibility. There are several different 3-D printing methods for both metal and plastics. They...

May 1st, 2015
0

Long FDA timelines and voracious cash requirements from portfolio companies have hobbled medtech angels in recent years.

Wende Hutton

The obstacle course of medtech innovation has proven so tough that another casualty is now on the horizon.

Instead of emerging as the winner of the race, angels and incubators are stumbling over one too many reroutes at FDA and treacherous paths to future financings. These early stag financiers are no longer lining up at the starting line with resources to take the place of dried-up venture dollars, leaving the ecosystem even more stretched to keep medtech leadership alive in the US.

While 2014 saw an enormous influx of $9 billion venture dollars into healthcare with an average round of $16.5 million dollars into Seed and Series A, medical device deals lagged the...

May 1st, 2015
0

A relatively new technology has proven hackable by a group of academic researchers.

Marie Thibault

It seems nothing is safe anymore. The potential perils of hackers attacking lifesaving devices like insulin pumps and ICDs may already be well-known in the medtech community. However, the idea that patients could be harmed or even killed by remote tech-savvy villains is still shocking to most.

But those devices seem relatively banal compared to the latest medical technology to undergo testing by researchers who want to uncover its hackable shortcomings: telerobotic surgery. Killer robots, anyone?

Telerobotic surgery is still a novel concept to many. It essentially allows an...

May 1st, 2015
0

A Zimmer executive explains to analysts why his company has so far steered clear of two major trends in orthopedics: robotics and value implants. 

Marie Thibault

While many of their peers have turned toward technologies like robotics or to cost-saving offerings like value implants, it seems Zimmer plans to stay away from those hot trends, at least for now.

This is notable because some of Zimmer's biggest competitors—Stryker, Smith & Nephew, and Johnson & Johnson—have either entered or announced plans to enter the robotic space. In...

April 30th, 2015
0